Shopping Cart
- Remove All
Your shopping cart is currently empty
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $39 | In Stock | |
| 10 mg | $62 | In Stock | |
| 25 mg | $119 | In Stock | |
| 50 mg | $188 | In Stock | |
| 100 mg | $271 | In Stock | |
| 200 mg | $383 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $41 | In Stock |
| Description | Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy. |
| Targets&IC50 | NNRT:119 nM (IC50) |
| Synonyms | UK-453061, Lersivirine(UK 453061) |
| Molecular Weight | 310.35 |
| Formula | C17H18N4O2 |
| Cas No. | 473921-12-9 |
| Smiles | CCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N |
| Relative Density. | 1.19 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (161.11 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.